GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sienna Biopharmaceuticals SNNAQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2018

Net income

−$73.3m

FY2015FY2018

Free cash flow

−$61.7m

FY2015FY2018

Shareholders' equity

$159.4m

FY2015FY2018

Income statement

Fiscal years

FY2018FY2017FY2016FY2015
Gross profit−$157,000−$120,000−$67,000−$32,000
Research and development$51.6m$30.5m$11.0m$2.4m
Operating income−$76.5m−$48.6m−$20.7m−$11.1m
Net income−$73.3m−$50.5m−$21.8m−$11.3m
Diluted earnings per share-3.52-2.51-11.03-0.37

Balance sheet

At each fiscal year end

FY2018FY2017FY2016FY2015
Total assets$107.3m$136.8m$62.4m$5.8m
Cash and short-term investments$48.5m$74.5m$9.1m$5.0m
Total liabilities$80.7m$45.6m$40.3m$1.7m
Debt$30.1m———
Shareholders' equity$159.4m$85.9m$22.1m$4.1m
Shares outstanding21m20m2m31m

Cash flow

Fiscal years

FY2018FY2017FY2016FY2015
Cash from operations−$61.7m−$41.1m−$17.7m−$10.0m
Capital spending−$39,000−$274,000−$238,000−$88,000
Free cash flow−$61.7m−$41.4m−$17.9m−$10.1m
Dividends paid———−$45.4m

Latest quarters

By quarter end

Sept 2019Jun 2019Mar 2019Dec 2018Sept 2018Jun 2018Mar 2018Dec 2017
Operating income−$6.0m−$7.7m−$15.8m−$19.8m−$16.6m−$21.7m−$18.5m−$14.0m
Net income−$4.0m−$8.3m−$16.4m−$19.3m−$16.8m−$20.2m−$17.1m−$11.2m
Diluted earnings per share-0.13-0.27-0.53-0.93-0.81-0.97-0.82-0.56
Cash from operations−$17.0m−$8.0m−$12.0m−$15.0m−$15.0m−$15.0m−$14.0m−$14.0m
Total assets$43.5m$107.6m$115.1m$107.3m$124.6m$135.7m$123.5m$136.8m
Cash and short-term investments$11.3m$49.2m$57.2m$48.5m$64.0m$74.9m$60.0m$74.5m
Debt$10.1m$29.5m$29.5m$30.1m————
Shareholders' equity$23.1m$27.0m$33.3m$159.4m$44.9m$55.5m$76.4m$85.9m

Share price return

Finished calendar years

202520242023202220212020201920182017
Return0%0%0%0%-43%-48%-86%-82%29%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.